• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓形成诊所中白塞病的患病率

The Prevalence of Behçet's Disease in a Thrombosis Clinic.

作者信息

Merashli Mira, Ames Paul Rj

机构信息

Department of Internal Medicine, Rheumatology Division, American University of Beirut, Beirut, Lebanon.

CEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisboa, Portugal.

出版信息

Mediterr J Rheumatol. 2023 Feb 21;34(1):66-70. doi: 10.31138/mjr.34.1.66. eCollection 2023 Mar.

DOI:10.31138/mjr.34.1.66
PMID:37223605
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10201090/
Abstract

BACKGROUND

the prevalence of venous thromboembolism (VTE) in Behcet's disease (BD) is around 40%, though recognition of BD in a thrombosis clinic has been poorly addressed.

OBJECTIVE

to evaluate the prevalence of signs and symptoms leading to the diagnosis of BD in a thrombosis clinic compared to patients attending a general haematology clinic and to healthy controls. Design: cross-sectional case-double control anonymous questionnaire survey. Participants: consecutive patients with spontaneous VTE (n=97) attending a thrombosis clinic, consecutive patients from a general haematology (GH) clinic (n=89) and controls (CTR).

RESULTS

BD was diagnosed in 1.03% of VTE participants, in 2.2% of GH participants and in 1.2% of healthy CTR. Exhaustion was more common reported in participants from the VTE group (15.6%) than in those from the GH group (10.3%) and from the healthy CTR (3%) (p=0.06); the sum of signs and symptoms of BD clustered in the VTE group (89.5%) compared to the GH (72.4%) and the CTR (59.7%) (p<0.0001).

CONCLUSIONS

BD may be diagnosed in 1 every 100 patients with VTE attending a thrombosis clinic and in 2 every 100 patients attending a GH clinic: awareness must be raised not to under-diagnose or misdiagnose BD in these settings as management of VTE in BD deviates from the norm.

摘要

背景

白塞病(BD)患者静脉血栓栓塞症(VTE)的患病率约为40%,尽管在血栓形成门诊对白塞病的识别情况较差。

目的

与普通血液科门诊患者及健康对照相比,评估血栓形成门诊中导致白塞病诊断的体征和症状的患病率。设计:横断面病例-双对照匿名问卷调查。参与者:血栓形成门诊的连续自发性VTE患者(n=97)、普通血液科(GH)门诊的连续患者(n=89)及对照(CTR)。

结果

VTE参与者中1.03%被诊断为白塞病,GH参与者中为2.2%,健康对照中为1.2%。VTE组参与者报告疲劳的情况(15.6%)比GH组(10.3%)和健康对照(3%)更常见(p=0.06);与GH组(72.4%)和CTR组(59.7%)相比,白塞病的体征和症状总和在VTE组更为集中(89.5%)(p<0.0001)。

结论

在血栓形成门诊就诊的每100例VTE患者中可能有1例被诊断为白塞病,在GH门诊就诊的每100例患者中有2例:必须提高认识,避免在这些情况下对白塞病诊断不足或误诊,因为白塞病中VTE的管理与常规不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342b/10201090/8e625b392e42/MJR-34-1-66-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342b/10201090/8e625b392e42/MJR-34-1-66-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/342b/10201090/8e625b392e42/MJR-34-1-66-g001.jpg

相似文献

1
The Prevalence of Behçet's Disease in a Thrombosis Clinic.血栓形成诊所中白塞病的患病率
Mediterr J Rheumatol. 2023 Feb 21;34(1):66-70. doi: 10.31138/mjr.34.1.66. eCollection 2023 Mar.
2
Thrombosis in Behçet's disease: a retrospective survey from a single UK centre.白塞病中的血栓形成:来自英国单一中心的回顾性调查。
Rheumatology (Oxford). 2001 Jun;40(6):652-5. doi: 10.1093/rheumatology/40.6.652.
3
Evaluation of asymptomatic venous disease by venous Doppler ultrasonography in patients with Behcet's disease without overt thrombosis.在无明显血栓形成的白塞病患者中,通过静脉多普勒超声评估无症状性静脉疾病。
Clin Rheumatol. 2014 Feb;33(2):277-80. doi: 10.1007/s10067-013-2382-4. Epub 2013 Sep 7.
4
Ultrasonographic measurement of the vascular wall thickness and intima-media thickness in patients with Behçet's disease with symptoms or signs of vascular involvement: A cross-sectional study.对有血管受累症状或体征的白塞病患者进行血管壁厚度和内膜中层厚度的超声测量:一项横断面研究。
Arch Rheumatol. 2021 Jan 14;36(2):258-266. doi: 10.46497/ArchRheumatol.2021.8423. eCollection 2021 Jun.
5
Epidemiology, morbidity and mortality in Behçet's disease: a cohort study using The Health Improvement Network (THIN).贝切特病的流行病学、发病率和死亡率:一项使用健康改善网络(THIN)的队列研究。
Rheumatology (Oxford). 2020 Oct 1;59(10):2785-2795. doi: 10.1093/rheumatology/keaa010.
6
Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.白塞病合并静脉血栓患者的血管内皮生长因子和单核细胞趋化蛋白-1
Clin Exp Rheumatol. 2005 Jul-Aug;23(4 Suppl 38):S42-8.
7
Lessons Learned From a Case of Behcet's Disease Presenting With Fever and Life-Threatening Venous Thromboembolism.从一例以发热和危及生命的静脉血栓栓塞为表现的白塞病病例中吸取的教训
Cureus. 2022 Dec 15;14(12):e32546. doi: 10.7759/cureus.32546. eCollection 2022 Dec.
8
Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?血清尿酸可能是白塞病中血栓形成和/或葡萄膜炎的危险因素吗?
Vascular. 2018 Aug;26(4):378-386. doi: 10.1177/1708538117742831. Epub 2018 Jan 23.
9
Cerebral venous sinus thrombosis in Behçet's disease: a retrospective case-control study.贝赫切特病性脑静脉窦血栓形成:一项回顾性病例对照研究。
Clin Rheumatol. 2018 Jan;37(1):51-57. doi: 10.1007/s10067-017-3718-2. Epub 2017 Jun 14.
10
Lesion probability map in cerebral vein thrombosis due to Behçet's disease.白塞病所致脑静脉血栓形成的病变概率图。
Int J Rheum Dis. 2023 Jan;26(1):145-150. doi: 10.1111/1756-185X.14455. Epub 2022 Oct 9.

本文引用的文献

1
Post Thrombotic Syndrome.血栓形成后综合征
Adv Exp Med Biol. 2017;906:363-375. doi: 10.1007/5584_2016_126.
2
[Cardiovascular involvement in Behçet's disease].[白塞病的心血管受累情况]
Rev Med Interne. 2014 Feb;35(2):103-11. doi: 10.1016/j.revmed.2013.12.002. Epub 2014 Jan 13.
3
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.《世界医学协会赫尔辛基宣言:涉及人类受试者的医学研究伦理原则》
JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053.
4
The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.国际白塞病诊断标准(ICBD):27 个国家对新标准敏感性和特异性的合作研究。
J Eur Acad Dermatol Venereol. 2014 Mar;28(3):338-47. doi: 10.1111/jdv.12107. Epub 2013 Feb 26.
5
Immunosuppressants reduce venous thrombosis relapse in Behçet's disease.免疫抑制剂可降低白塞病患者静脉血栓形成的复发率。
Arthritis Rheum. 2012 Aug;64(8):2753-60. doi: 10.1002/art.34450.
6
Association of fatigue and psychological distress with quality of life in patients with a previous venous thromboembolic event.曾有静脉血栓栓塞事件的患者的疲劳和心理困扰与生活质量的关联。
Thromb Haemost. 2009 Dec;102(6):1219-26. doi: 10.1160/TH09-05-0316.
7
Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration.基于人群的白塞病患病率研究:按种族划分的差异及移民时年龄的低变异性
Arthritis Rheum. 2008 Dec;58(12):3951-9. doi: 10.1002/art.24149.
8
Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases.白塞病的血管受累情况:2319例病例的回顾性分析
Int J Dermatol. 2006 Aug;45(8):919-21. doi: 10.1111/j.1365-4632.2006.02832.x.
9
The prevalence of Behçet's syndrome and its neurological complications in Hertfordshire, U.K.英国赫特福德郡白塞病及其神经系统并发症的患病率
Adv Exp Med Biol. 2003;528:95-7. doi: 10.1007/0-306-48382-3_19.
10
The multiple faces of Behçet's disease and its aetiological factors.白塞病的多面性及其病因学因素。
J Eur Acad Dermatol Venereol. 2001 Mar;15(2):126-36. doi: 10.1046/j.1468-3083.2001.00251.x.